omitir hasta el contenido
Prescription drugs Ver este material de antemano
CerrarVer este material de antemano

Prescription drugs

Autor: Sylvia Engdahl
Editorial: Detroit : Greenhaven Press/Gale Cengage Learning, ©2008.
Serie: Current controversies.
Edición/Formato:   Print book : Inglés (eng)Ver todas las ediciones y todos los formatos
Base de datos:WorldCat
Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications.

(todavía no calificado) 0 con reseñas - Ser el primero.

Más materiales como éste


Encontrar un ejemplar en la biblioteca

&AllPage.SpinnerRetrieving; Encontrando bibliotecas que tienen este material…


Formato físico adicional: Online version:
Prescription drugs.
Detroit : Greenhaven Press/Gale Cengage Learning, ©2008
Tipo de material: Recurso en Internet
Tipo de documento: Libro/Texto, Recurso en Internet
Todos autores / colaboradores: Sylvia Engdahl
ISBN: 9780737739626 0737739622 9780737739633 0737739630
Número OCLC: 192079717
Descripción: 246 pages ; 24 cm.
Contenido: Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir --
Some prescription drugs on the market are unsafe / Consumer reports --
Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher --
Post-marketing study of prescription drugs is not adequate / David J. Graham --
No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb --
Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine --
Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller --
Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross --
Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere --
Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados --
Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels --
Drug promotion plays on people's fears of future illness / Barbara Mintzes --
Drug promotion has led to the overmedication of children / Anne Taylor Fleming --
No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds --
Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer --
Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony. Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --
Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider --
Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett --
New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello --
No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber --
Medical innovation would stop if the government controlled drug prices / Sidney Taurel --
Controlling drug prices would reduce access to medicine / Doug Bandow --
Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari --
Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick --
Prescription drugs are often abused / Nichole Aksamit --
Young people often trade prescription drugs with friends / Amy Harmon --
Teens use prescription drugs to get high / Donna Leinwand.
Título de la serie: Current controversies.
Responsabilidad: Sylvia Engdahl, book editor.
Más información:


Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications.


Reseñas contribuidas por usuarios
Recuperando reseñas de GoodReads…
Recuperando reseñas de DOGObooks…


Ser el primero.

Materiales similares

Temas relacionados:(3)

Listas de usuarios con este material (2)

Confirmar este pedido

Ya ha pedido este material. Escoja OK si desea procesar el pedido de todos modos.

Datos enlazados

Primary Entity

<> # Prescription drugs
    a schema:CreativeWork, schema:Book ;
    library:oclcnum "192079717" ;
    library:placeOfPublication <> ; # Detroit
    library:placeOfPublication <> ;
    schema:about <> ; # Drugs--Public opinion
    schema:about <> ; # Pharmaceutical industry
    schema:about <> ; # Pharmaceutical policy
    schema:about <> ;
    schema:about <> ; # Drugs--Public opinion
    schema:about <> ;
    schema:bookFormat bgn:PrintBook ;
    schema:contributor <> ; # Sylvia Engdahl
    schema:copyrightYear "2008" ;
    schema:datePublished "2008" ;
    schema:description "Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications."@en ;
    schema:exampleOfWork <> ;
    schema:inLanguage "en" ;
    schema:isPartOf <> ; # Current controversies.
    schema:isSimilarTo <> ;
    schema:name "Prescription drugs"@en ;
    schema:productID "192079717" ;
    schema:publication <> ;
    schema:publisher <> ; # Greenhaven Press/Gale Cengage Learning
    schema:url <> ;
    schema:workExample <> ;
    schema:workExample <> ;
    wdrs:describedby <> ;

Related Entities

<> # Greenhaven Press/Gale Cengage Learning
    a bgn:Agent ;
    schema:name "Greenhaven Press/Gale Cengage Learning" ;

<> # Current controversies.
    a bgn:PublicationSeries ;
    schema:hasPart <> ; # Prescription drugs
    schema:name "Current controversies." ;
    schema:name "Current controversies" ;

<> # Pharmaceutical industry
    a schema:Intangible ;
    schema:name "Pharmaceutical industry"@en ;

<> # Pharmaceutical policy
    a schema:Intangible ;
    schema:name "Pharmaceutical policy"@en ;

<> # Drugs--Public opinion
    a schema:Intangible ;
    schema:name "Drugs--Public opinion"@en ;

<> # Sylvia Engdahl
    a schema:Person ;
    schema:familyName "Engdahl" ;
    schema:givenName "Sylvia" ;
    schema:name "Sylvia Engdahl" ;

    a schema:ProductModel ;
    schema:isbn "0737739622" ;
    schema:isbn "9780737739626" ;

    a schema:ProductModel ;
    schema:isbn "0737739630" ;
    schema:isbn "9780737739633" ;

    a schema:CreativeWork ;
    rdfs:label "Prescription drugs." ;
    schema:description "Online version:" ;
    schema:isSimilarTo <> ; # Prescription drugs

Content-negotiable representations

Cerrar ventana

Inicie una sesión con WorldCat 

¿No tienes una cuenta? Puede fácilmente crear una cuenta gratuita.